Press Releases

With a CAGR of 12.5%, the global pyrogen testing market is expected to witness significant growth during the forecast period. The increasing prevalence of communicable diseases and epidemics are the reasons for the demand for pyrogen testing techniques during the forecast period 2023-2030. The increased investment in research and development activities by manufacturing companies and initiatives by the government for new product development will contribute to the growth of the pyrogen testing market. Nevertheless, the rising number of outsourcing activities in the pharmaceutical sector will provide promising opportunities for the growth of the pyrogen testing market.

Lonza has launched the PyroCell monocyte activation test system to provide reliable and sustainable in vitro pyrogen tests for primary cells and endotoxin tests.

The increased demand for in-vitro assays to identify the presence and concentration of bacterial endotoxins in biological products and drugs will fuel steady growth during the COVID-19 outbreak.

Browse 50 market data Tables and 35 Figures spread through 200 Pages and in-depth TOC on " Pyrogen Testing Market by Product (Kits and Reagents, Instruments and Services), by Application (Pharmaceutical and Biological Manufacturing, Medical Device Manufacturing and Others) and by Test Type (LAL Tests, Rabbit Tests, and In Vitro Tests), and Region - Global Forecast to 2030"

By application, medical device manufacturing is projected to witness the highest CAGR during the forecast period.

Based upon application, medical device manufacturing is anticipated to witness high CAGR in the pyrogen testing market during 2023-2030 owing to the introduction of technologically developed products and rising demand for high-quality medical devices for therapeutic and diagnostic applications that will fuel the growth of the segment.

Global Pyrogen Testing Market Segmentation Analysis

Discover More About This Report, Download A Free Sample Copy of Global Pyrogen Testing Market

“North-America to hold the largest regional market share of pyrogen testing in 2022.”

North America dominates the pyrogen testing market owing to the prominence of chronic and infectious diseases, well-developed regulatory framework, increasing presence of pharmaceutical companies, and developments in R&D activities.

Some of the major players in the pyrogen testing market include Associates of Cape Cod, Inc., Merck KGaA, Thermo Fisher Scientific, Inc., GenScript, Charles River Laboratories, Inc., Ellab A/S, Lonza Group, and WUXI Pharmatech (Cayman) Inc.

Scope of the Report

Global Pyrogen Testing Market Coverage

Product Insight and Forecast 2018-2030

• Kits and Reagents
• Instruments and Services

Application Insight and Forecast 2018-2030

• Pharmaceutical and Biological Manufacturing
• Medical Device Manufacturing
• Others

Test Type Insight and Forecast 2018-2030

• LAL Tests
• Rabbit Tests
• In Vitro Tests

Geographical Segmentation

Pyrogen Testing Market by Region

North America

• By Product
• By Application
• By Test Type
• By Country – U.S., Canada, and Mexico

Europe

• By Product
• By Application
• By Test Type
• By Country – Germany, U.K., France, Italy, Spain, Russia, and Rest of Europe

Asia-Pacific (APAC)

• By Product
• By Application
• By Test Type
• By Country – China, Japan, India, South Korea, and Rest of Asia-Pacific

Rest of the World (RoW)

• By Product
• By Application
• By Test Type
• By Country – Brazil, Saudi Arabia, South Africa, U.A.E., and Other Countries